Last reviewed · How we verify
NCT05150470: DPOAM
Evaluation of the Dental Movements Caused by Oral Appliance in Sleep Apnea Syndrome
NA trial testing prevention in Sleep Apnea Syndromes in 180 participants. Completed in 25 December 2022.
25 November 2022
Quick facts
| Lead sponsor | Centre Hospitalier de Valence |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 180 |
| Start date | 25 November 2021 |
| Primary completion | 25 November 2022 |
| Estimated completion | 25 December 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- prevention
Conditions studied
- Sleep Apnea Syndromes — all drugs for Sleep Apnea Syndromes →
Sponsor
Centre Hospitalier de Valence
Who can join
18 and older, any sex, with Sleep Apnea Syndromes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The DO OAM study is a mono-center, interventional, prospective study carried out in CH VALENCE. It will estimate the prevalence of dental movements in patients treated by oral Appliance for Sleep Apnea syndrome. The investigators will used fingerprinting technique by taking multiple photographs of the teeth that allow for the three-dimensional reconstruction of the teeth this study will provide a better understanding of dental movement caused by oral appliance
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05150470
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Apnea Syndromes
Currently open trials in the same condition.
- NCT06578390 — Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis · NA · recruiting
- NCT07086599 — Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Pari · recruiting
- NCT04399200 — Apnea, Stroke and Incident Cardiovascular Events · recruiting
- NCT04234828 — Validation of Withings Sleep for the Detection of Sleep Apnea Syndrome · active not recruiting
Other Centre Hospitalier de Valence trials
Trials by the same sponsor.
- NCT06184880 — Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer · NA · recruiting
- NCT05618392 — Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors · recruiting
- NCT05227157 — GOUTMETALSAIN: Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers · completed
- NCT05056766 — How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each · completed
- NCT05497947 — Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLarynge · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05150470 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Valence
- Last refreshed: 8 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150470.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing